Located in Maple Grove, Minnesota, StemoniX has developed a human-induced cardiac screening tool with the goal of improving and speeding up neurotoxicity research and medication testing. The company's current pipeline includes Rusfertide (PTG-300), an injectable hepcidin mimetic currently in a Phase 2 proof-of-concept clinical trial for polycythemia vera, a type of blood cancer.ĭirector, Research and Development - Cassiano Carromeu Located in Newark, California, Protagonist Therapeutics has developed a patented technology platform to meet large unmet medical needs. Located in Cambridge, Massachusetts, Cellino uses image-guided machine learning, single-cell laser processing, and robotics to create autologous induced pluripotent stem cells (iPSCs) at scale, allowing healthcare professionals to speed up the creation of life-saving medications for patients. NK- and T-cell immuno-oncology initiatives, including off-the-shelf engineered product candidates produced from clonal master iPSC lines, and immuno-regulatory programs, make up the company's cell therapy pipeline. Located in San Diego, CA, Fate Therapeutics works on cancer and immunological illnesses by developing programmed cellular immunotherapies. The company has created several processing and treatment methodologies and published about half of all studies on the use of mesenchymal stem cells for the treatment of orthopedic injuries, allowing clinicians to treat orthopedic injuries. Located in Des Moines, Iowa, Regenexx has invented a patented orthopedic technique to lower orthopedic costs and improve patient results. They are developing pluripotent stem cells with the goal of replacing any missing or damaged cells in the body, is the next step and creating new delivery methods to deliver any payload to any cell in a precise, predictable, and repeatable manner, opening the way for next-generation in vivo gene therapy. Located in Seattle, Washington, Sana Biotechnology is dedicated to developing modified cells as therapeutics for patients. Located in Cambridge, Massachusetts, Rubius Therapeutics is developing red cell therapeutics (RCTs) to treat uncommon disorders, cancer, and autoimmune diseases. It is also working on HIV vaccines and treatments, as well as cellular immuno-oncology medicines. It researches and develops cures for infectious diseases and cancer. Located in Los Angeles, California, Enochian Biosciences focuses on finding, developing, manufacturing, and marketing gene treatments. Įxecutive Vice President, Research and Development - Francois Binette Located in Cambridge, Massachusetts, Magenta Therapeutics is working on new drugs to boost stem cell transplant, gene therapy, genome editing, and cell therapy's curative abilities. The company's platform combines cutting-edge genomic AI with pluripotent stem cell biology to deliver patient-specific restorative cell therapy that alters disease progression. Located in La Jolla, California, Aspen Neuroscience develops autologous cell treatments and tailored medicines for various disorders, beginning with Parkinson's disease. President, CEO, & Board Member - Damien McDevitt Here are 20 innovative stem cell companies in the US: A report from Grand View Research projects that the stem cell market will reach US$18.4 billion by 2028. The stem cell therapy market is expected to experience meteoric growth over the next few years. Stem cells are cells in the body that have the ability to differentiate into a variety of different cell types, including muscle tissue, bone marrow and organ-specific cells.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |